v3.24.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash, cash equivalents and current restricted cash $ 406,400 $ 95,881
Accounts receivable, net 106,579 123,379
Inventory, net 59,408 65,697
Other current assets and prepaid expenses 57,249 24,519
Total current assets 629,636 309,476
Property, plant and equipment, net 72,271 75,429
Intangible assets, net 641,396 740,283
In-process research and development 195,000 195,000
Goodwill 535,868 598,260
Investments 100,609 16,082
Operating lease right-of-use assets 62,812 68,088
Other assets 18,511 9,080
Total assets 2,256,103 2,011,698
Current liabilities:    
Accounts payable 62,721 69,677
Accrued expenses 122,806 90,086
Current maturities of operating leases 12,741 12,996
Current portion of convertible notes 170 0
Current portion of lines of credit and notes payable 13,222 27,293
Total current liabilities 211,660 200,052
Operating lease liabilities 52,057 54,140
Long term portion of convertible notes 178,695 214,325
Senior secured notes 245,358 0
Deferred tax liabilities 128,412 126,773
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 36,504 27,189
Total long-term liabilities 641,026 422,427
Total liabilities 852,686 622,479
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 712,283,206 and 781,936,885 shares issued at September 30, 2024 and December 31, 2023, respectively 7,124 7,820
Treasury Stock - 29,800,177, and 8,655,082 shares at September 30, 2024 and December 31, 2023, respectively (1,791) (1,791)
Additional paid-in capital 3,516,735 3,433,006
Accumulated other comprehensive loss (39,614) (38,030)
Accumulated deficit (2,079,037) (2,011,786)
Total shareholders’ equity 1,403,417 1,389,219
Total liabilities and equity $ 2,256,103 $ 2,011,698

Source

HTML PDF
ZIP